CA2237701A1 - Proteines liantes smad - Google Patents
Proteines liantes smad Download PDFInfo
- Publication number
- CA2237701A1 CA2237701A1 CA 2237701 CA2237701A CA2237701A1 CA 2237701 A1 CA2237701 A1 CA 2237701A1 CA 2237701 CA2237701 CA 2237701 CA 2237701 A CA2237701 A CA 2237701A CA 2237701 A1 CA2237701 A1 CA 2237701A1
- Authority
- CA
- Canada
- Prior art keywords
- sara
- smad2
- protein
- receptor
- signalling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000021120 SMAD binding proteins Human genes 0.000 title description 2
- 108091011127 SMAD binding proteins Proteins 0.000 title description 2
- 101000964562 Homo sapiens Zinc finger FYVE domain-containing protein 9 Proteins 0.000 description 243
- 102100040801 Zinc finger FYVE domain-containing protein 9 Human genes 0.000 description 236
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 177
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 161
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 157
- 108020003175 receptors Proteins 0.000 description 103
- 102000005962 receptors Human genes 0.000 description 103
- 108090000623 proteins and genes Proteins 0.000 description 96
- 102000004169 proteins and genes Human genes 0.000 description 85
- 210000004027 cell Anatomy 0.000 description 82
- 235000018102 proteins Nutrition 0.000 description 79
- 102000009618 Transforming Growth Factors Human genes 0.000 description 65
- 108010009583 Transforming Growth Factors Proteins 0.000 description 65
- 230000011664 signaling Effects 0.000 description 65
- 101000759188 Homo sapiens Zinc finger FYVE domain-containing protein 16 Proteins 0.000 description 57
- 230000027455 binding Effects 0.000 description 49
- 102000044289 human ZFYVE16 Human genes 0.000 description 48
- 230000003993 interaction Effects 0.000 description 44
- 102000049937 Smad4 Human genes 0.000 description 40
- 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 36
- 230000004807 localization Effects 0.000 description 35
- 230000026731 phosphorylation Effects 0.000 description 29
- 238000006366 phosphorylation reaction Methods 0.000 description 29
- 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 26
- 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 26
- 230000006870 function Effects 0.000 description 25
- 230000014509 gene expression Effects 0.000 description 25
- 230000004913 activation Effects 0.000 description 24
- 238000000034 method Methods 0.000 description 23
- 230000019491 signal transduction Effects 0.000 description 23
- 108091000080 Phosphotransferase Proteins 0.000 description 18
- 102000020233 phosphotransferase Human genes 0.000 description 18
- 108700032182 Xenopus ZFYVE9 Proteins 0.000 description 17
- 235000001014 amino acid Nutrition 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 108090000765 processed proteins & peptides Proteins 0.000 description 17
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 16
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 16
- 102000007374 Smad Proteins Human genes 0.000 description 16
- 108010007945 Smad Proteins Proteins 0.000 description 16
- 125000003275 alpha amino acid group Chemical group 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 16
- 229940112869 bone morphogenetic protein Drugs 0.000 description 16
- 239000002299 complementary DNA Substances 0.000 description 16
- 102000037865 fusion proteins Human genes 0.000 description 16
- 108020001507 fusion proteins Proteins 0.000 description 16
- 230000037361 pathway Effects 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 15
- 239000012634 fragment Substances 0.000 description 15
- 230000004960 subcellular localization Effects 0.000 description 15
- 239000013592 cell lysate Substances 0.000 description 14
- 230000001419 dependent effect Effects 0.000 description 14
- 230000001105 regulatory effect Effects 0.000 description 14
- 238000003119 immunoblot Methods 0.000 description 13
- 238000012217 deletion Methods 0.000 description 12
- 230000037430 deletion Effects 0.000 description 12
- 238000001114 immunoprecipitation Methods 0.000 description 12
- 102000040430 polynucleotide Human genes 0.000 description 12
- 108091033319 polynucleotide Proteins 0.000 description 12
- 239000002157 polynucleotide Substances 0.000 description 12
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 108010059616 Activins Proteins 0.000 description 10
- 241000269370 Xenopus <genus> Species 0.000 description 10
- 239000000488 activin Substances 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 10
- 125000003729 nucleotide group Chemical group 0.000 description 10
- 238000003752 polymerase chain reaction Methods 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 102100026818 Inhibin beta E chain Human genes 0.000 description 9
- 238000010494 dissociation reaction Methods 0.000 description 9
- 230000005593 dissociations Effects 0.000 description 9
- 230000036961 partial effect Effects 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 description 8
- 108700026244 Open Reading Frames Proteins 0.000 description 8
- 102100023385 Zinc finger FYVE domain-containing protein 16 Human genes 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 210000004899 c-terminal region Anatomy 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- 230000002950 deficient Effects 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 239000006166 lysate Substances 0.000 description 8
- 239000013615 primer Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 230000002103 transcriptional effect Effects 0.000 description 8
- 102000005720 Glutathione transferase Human genes 0.000 description 7
- 108010070675 Glutathione transferase Proteins 0.000 description 7
- 101700032040 SMAD1 Proteins 0.000 description 7
- 238000004624 confocal microscopy Methods 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 239000003446 ligand Substances 0.000 description 7
- 210000004962 mammalian cell Anatomy 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- 241000283707 Capra Species 0.000 description 6
- 101000835893 Homo sapiens Mothers against decapentaplegic homolog 4 Proteins 0.000 description 6
- 101100041709 Homo sapiens SAR1B gene Proteins 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 101150109894 TGFA gene Proteins 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 238000004873 anchoring Methods 0.000 description 6
- 238000000376 autoradiography Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 108091005682 Receptor kinases Proteins 0.000 description 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- 102100032123 AMP deaminase 1 Human genes 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 4
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 4
- 101710191461 F420-dependent glucose-6-phosphate dehydrogenase Proteins 0.000 description 4
- 102100038635 FYVE, RhoGEF and PH domain-containing protein 1 Human genes 0.000 description 4
- 230000000692 anti-sense effect Effects 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
- 238000010820 immunofluorescence microscopy Methods 0.000 description 4
- 239000012133 immunoprecipitate Substances 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 230000005937 nuclear translocation Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 108010052946 Activin Receptors Proteins 0.000 description 3
- 102000018918 Activin Receptors Human genes 0.000 description 3
- 101100205030 Caenorhabditis elegans hars-1 gene Proteins 0.000 description 3
- 101100257127 Caenorhabditis elegans sma-2 gene Proteins 0.000 description 3
- 101100257133 Caenorhabditis elegans sma-3 gene Proteins 0.000 description 3
- 108700008039 Drosophila MAD Proteins 0.000 description 3
- 101100455918 Drosophila melanogaster Mad gene Proteins 0.000 description 3
- 102100041002 Forkhead box protein H1 Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101000835877 Homo sapiens Mothers against decapentaplegic homolog 2 Proteins 0.000 description 3
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 3
- 108060001084 Luciferase Proteins 0.000 description 3
- 239000005089 Luciferase Substances 0.000 description 3
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 3
- 101710143113 Mothers against decapentaplegic homolog 5 Proteins 0.000 description 3
- 102100030610 Mothers against decapentaplegic homolog 5 Human genes 0.000 description 3
- 102100030590 Mothers against decapentaplegic homolog 6 Human genes 0.000 description 3
- 101710143114 Mothers against decapentaplegic homolog 6 Proteins 0.000 description 3
- 101100290026 Mus musculus Mxd1 gene Proteins 0.000 description 3
- 102000008300 Mutant Proteins Human genes 0.000 description 3
- 108010021466 Mutant Proteins Proteins 0.000 description 3
- 230000010799 Receptor Interactions Effects 0.000 description 3
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 3
- 101100446119 Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) fabZ gene Proteins 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000008045 co-localization Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 208000023463 mandibuloacral dysplasia Diseases 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000002987 primer (paints) Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 210000003934 vacuole Anatomy 0.000 description 3
- 101100298412 Arabidopsis thaliana PCMP-H73 gene Proteins 0.000 description 2
- 108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 description 2
- 102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 description 2
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
- 230000005724 C-terminal phosphorylation Effects 0.000 description 2
- 101100008646 Caenorhabditis elegans daf-3 gene Proteins 0.000 description 2
- 101100257134 Caenorhabditis elegans sma-4 gene Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 101150053895 Foxh1 gene Proteins 0.000 description 2
- 102100022557 Hepatocyte growth factor-regulated tyrosine kinase substrate Human genes 0.000 description 2
- 101001045469 Homo sapiens Hepatocyte growth factor-regulated tyrosine kinase substrate Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 102000005601 Receptor-Regulated Smad Proteins Human genes 0.000 description 2
- 108010084447 Receptor-Regulated Smad Proteins Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 210000000172 cytosol Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003028 elevating effect Effects 0.000 description 2
- 210000001163 endosome Anatomy 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 210000001647 gastrula Anatomy 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000004942 nuclear accumulation Effects 0.000 description 2
- 238000012758 nuclear staining Methods 0.000 description 2
- 101150096366 pep7 gene Proteins 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- UBWXUGDQUBIEIZ-UHFFFAOYSA-N (13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl) 3-phenylpropanoate Chemical compound CC12CCC(C3CCC(=O)C=C3CC3)C3C1CCC2OC(=O)CCC1=CC=CC=C1 UBWXUGDQUBIEIZ-UHFFFAOYSA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- 102100038028 1-phosphatidylinositol 3-phosphate 5-kinase Human genes 0.000 description 1
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- -1 7 and 9 Proteins 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 208000002618 Aarskog syndrome Diseases 0.000 description 1
- 208000033745 Aarskog-Scott syndrome Diseases 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108091060211 Expressed sequence tag Proteins 0.000 description 1
- 241000714174 Feline sarcoma virus Species 0.000 description 1
- 108090000852 Forkhead Transcription Factors Proteins 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100032174 GTP-binding protein SAR1a Human genes 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010067218 Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
- 102000016285 Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
- 102000027430 HGF receptors Human genes 0.000 description 1
- 108091008603 HGF receptors Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001608644 Hippoboscidae Species 0.000 description 1
- 101001025044 Homo sapiens 1-phosphatidylinositol 3-phosphate 5-kinase Proteins 0.000 description 1
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
- 101001031750 Homo sapiens FYVE, RhoGEF and PH domain-containing protein 1 Proteins 0.000 description 1
- 101000892840 Homo sapiens Forkhead box protein H1 Proteins 0.000 description 1
- 101000637622 Homo sapiens GTP-binding protein SAR1a Proteins 0.000 description 1
- 101000835862 Homo sapiens Mothers against decapentaplegic homolog 1 Proteins 0.000 description 1
- 101000835874 Homo sapiens Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
- 101000605403 Homo sapiens Plasminogen Proteins 0.000 description 1
- 101100041700 Homo sapiens SAR1A gene Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100174574 Mus musculus Pikfyve gene Proteins 0.000 description 1
- 101100425739 Mus musculus Tnnc1 gene Proteins 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- UIQMVEYFGZJHCZ-SSTWWWIQSA-N Nalorphine Chemical compound C([C@@H](N(CC1)CC=C)[C@@H]2C=C[C@@H]3O)C4=CC=C(O)C5=C4[C@@]21[C@H]3O5 UIQMVEYFGZJHCZ-SSTWWWIQSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 101700031501 SMAD9 Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101710204410 Scaffold protein Proteins 0.000 description 1
- 101710184528 Scaffolding protein Proteins 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 108700032504 Smad2 Proteins 0.000 description 1
- 101150102611 Smad2 gene Proteins 0.000 description 1
- 108700031298 Smad4 Proteins 0.000 description 1
- 102000049870 Smad8 Human genes 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 108700021595 Xenopus Smad8 Proteins 0.000 description 1
- 108700038175 YAP-Signaling Proteins Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 102000035181 adaptor proteins Human genes 0.000 description 1
- 108091005764 adaptor proteins Proteins 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical group N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000007783 downstream signaling Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000002121 endocytic effect Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000001985 kidney epithelial cell Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000120 microwave digestion Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000008689 nuclear function Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 230000001582 osteoblastic effect Effects 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 239000000816 peptidomimetic Substances 0.000 description 1
- 108091005706 peripheral membrane proteins Proteins 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000003911 phosphatidylinositol 4-phosphates Chemical class 0.000 description 1
- 125000005642 phosphothioate group Chemical group 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 108009000000 signalling pathways Proteins 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000025934 tissue morphogenesis Effects 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- NBIIXXVUZAFLBC-HOSYLAQJSA-K trioxido(oxo)-$l^{5}-phosphane Chemical compound [O-][32P]([O-])([O-])=O NBIIXXVUZAFLBC-HOSYLAQJSA-K 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2237701 CA2237701A1 (fr) | 1998-07-20 | 1998-07-20 | Proteines liantes smad |
| CA002253647A CA2253647A1 (fr) | 1998-07-20 | 1998-12-10 | Proteines liantes smad |
| AU47663/99A AU4766399A (en) | 1998-07-20 | 1999-07-20 | Sara proteins |
| PCT/CA1999/000656 WO2000005360A1 (fr) | 1998-07-20 | 1999-07-20 | Proteines sara |
| CA002335346A CA2335346A1 (fr) | 1998-07-20 | 1999-07-20 | Proteines sara |
| US09/744,167 US7105636B1 (en) | 1998-07-20 | 1999-07-20 | SARA proteins |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2237701 CA2237701A1 (fr) | 1998-07-20 | 1998-07-20 | Proteines liantes smad |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2237701A1 true CA2237701A1 (fr) | 2000-01-20 |
Family
ID=29275719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2237701 Abandoned CA2237701A1 (fr) | 1998-07-20 | 1998-07-20 | Proteines liantes smad |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2237701A1 (fr) |
-
1998
- 1998-07-20 CA CA 2237701 patent/CA2237701A1/fr not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7560532B2 (en) | Smad6 and uses thereof | |
| CA2220753C (fr) | Nouveaux peptides et nouvelles compositions modulant l'apoptose | |
| US6605443B1 (en) | Method for identifying compounds that affect Smad7 binding | |
| AU741242B2 (en) | Smad2 phosphorylation and interaction with Smad4 | |
| JP2002525067A (ja) | レプチン誘導遺伝子 | |
| US7396920B2 (en) | Tumour suppressor and uses thereof | |
| US20070081987A1 (en) | Novel peptides and compositions which modulate apoptosis | |
| AU2001263952A1 (en) | Tumour suppressor and uses thereof | |
| WO1998007849A1 (fr) | Gene suppresseur de tumeur madr2 | |
| US7105636B1 (en) | SARA proteins | |
| US7635766B2 (en) | Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes | |
| US20020088015A1 (en) | Wilms' tumor wt1 binding proteins | |
| CA2237701A1 (fr) | Proteines liantes smad | |
| US6673570B1 (en) | Smad associating polypeptides | |
| EP1497305A2 (fr) | Proteine 1 de liaison a l'adn sensible a l'insuline et methodes destinees a reguler des genes sensibles a l'insuline | |
| US6991909B2 (en) | Enkurin and uses thereof | |
| CA2335346A1 (fr) | Proteines sara | |
| WO1998013494A2 (fr) | Proteine fixatrice du gene wt1 suppresseur de la tumeur de wilm | |
| WO1998013494A9 (fr) | Proteine fixatrice du gene wt1 suppresseur de la tumeur de wilm | |
| WO2001021794A9 (fr) | Polypeptides associant smad | |
| JP2003527108A (ja) | ポリペプチドおよびポリペプチドをコードする核酸 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |